Beta lactamase as biomarker for the specific detection of tuberculosis-complex bacteria Patent uri icon

abstract

  • The present disclosure provides methods, reagents, systems, and devices that target β lactamase as a biomarker for the sensitive and specific detection of tuberculosis-complex bacteria. Specifically, the present disclosure relates to methods and compositions for the detection of specific β-lactamase protein and nucleic acid sequences to indicate the presence of tuberculosis-complex bacteria.

author list (cited authors)

  • Cirillo, J. D., & Norman, M. T.

publication date

  • January 2019